Scholar Rock Holding Corp (SRRK)
29.77
+3.10
(+11.62%)
USD |
NASDAQ |
Nov 22, 15:12
Scholar Rock Shareholders Equity (Quarterly): 79.20M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 79.20M |
June 30, 2024 | 133.62M |
March 31, 2024 | 182.77M |
December 31, 2023 | 225.22M |
September 30, 2023 | 167.66M |
June 30, 2023 | 202.50M |
March 31, 2023 | 228.65M |
December 31, 2022 | 260.24M |
September 30, 2022 | 293.26M |
June 30, 2022 | 329.51M |
March 31, 2022 | 171.32M |
December 31, 2021 | 172.07M |
September 30, 2021 | 187.26M |
June 30, 2021 | 216.66M |
Date | Value |
---|---|
March 31, 2021 | 240.54M |
December 31, 2020 | 260.77M |
September 30, 2020 | 62.98M |
June 30, 2020 | 82.17M |
March 31, 2020 | 98.65M |
December 31, 2019 | 112.90M |
September 30, 2019 | 121.79M |
June 30, 2019 | 128.96M |
March 31, 2019 | 97.52M |
December 31, 2018 | 106.62M |
September 30, 2018 | 102.34M |
June 30, 2018 | 111.61M |
March 31, 2018 | 47.36M |
December 31, 2017 | -53.52M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
62.98M
Minimum
Sep 2020
329.51M
Maximum
Jun 2022
185.40M
Average
185.02M
Median
Shareholders Equity (Quarterly) Benchmarks
Cytokinetics Inc | -13.91M |
Regeneron Pharmaceuticals Inc | 29.33B |
Ocugen Inc | 40.63M |
Mirum Pharmaceuticals Inc | 232.02M |
NeuroBo Pharmaceuticals Inc | 12.95M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 179.13M |
Total Liabilities (Quarterly) | 99.94M |